ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,000 | -11.1% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | -25.0% | 400 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $12,000 | -36.8% | 400 | -20.0% | 0.00% | -40.0% |
| Q3 2017 | $19,000 | +11.8% | 500 | -16.7% | 0.01% | 0.0% |
| Q2 2017 | $17,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $17,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $17,000 | -10.5% | 600 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $19,000 | 0.0% | 600 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $19,000 | +35.7% | 600 | +20.0% | 0.01% | +16.7% |
| Q1 2016 | $14,000 | -22.2% | 500 | 0.0% | 0.01% | -64.7% |
| Q4 2015 | $18,000 | +38.5% | 500 | +25.0% | 0.02% | +183.3% |
| Q3 2015 | $13,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |